Abstract
The development of a method to mask bitter taste has been actively sought after in pharmaceutical and food science. A lipoprotein (PA-LG) was found in the present study to be composed of phosphatidic acid (PA) and β-lactoglobulin (LG) was noted to selectively and reversibly suppress frog taste nerve response and human taste sensation to various bitter substances without affecting sweetness, saltiness and sourness. PA would thus appear importantly involved in inhibiting bitterness since PA-containing lipoproteins showed inhibitory action irrespective of protein species. As for the mechanism of bitter suppression, PA-LG would appear to mask the receptor site for bitterness on taste receptor membrane. Inhibitory action forward bitterness by PA itself without protein or other phospholipids in humans was examined. PA and phosphatidylinositol (PI) inhibited the bitterness of various bitter substances without affecting the taste sensation of other taste stimuli, although inhibitory activity was less than that of PA-LG. A lecithin fraction containing high content PA and PI was thus prepared from soybean lecithin on an industrial scale. The lecithin fraction showed inhibitory activity forward bitterness. This fraction and PA were thus concluded effective means for masking the bitter taste of drugs and food.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.